Developing vaccines to combat hookworm infection and intestinal schistosomiasis

Nature Reviews Microbiology

Volumn 8, Issue 11, 2010, Pages 814-826

  Hotez, Peter J ^a   Bethony, Jeffrey M ^a,b   Diemert, David J ^a,b   Pearson, Mark ^c   Loukas, Alex ^c  

^a GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c JAMES COOK UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPARASITIC AGENT; BENZIMIDAZOLE; HOOKWORM VACCINE; PRAZIQUANTEL; SCHISTOSOMA VACCINE; UNCLASSIFIED DRUG;

DISEASE ASSOCIATION; HELMINTHIASIS; HOOKWORM INFECTION; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION PREVENTION; INTESTINAL SCHISTOSOMIASIS; IRON DEFICIENCY ANEMIA; MORBIDITY; MORTALITY; NECATOR AMERICANUS; NONHUMAN; PARASITE IMMUNITY; PRIORITY JOURNAL; REVIEW; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS;

ANEMIA; ANIMALS; ANTIGENS, HELMINTH; HOOKWORM INFECTIONS; HUMANS; NECATOR AMERICANUS; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; VACCINES; VACCINES, COMBINED;

ANCYLOSTOMATOIDEA; NECATOR AMERICANUS; SCHISTOSOMA; SCHISTOSOMA MANSONI;

EID: 77958082295     PISSN: 17401526     EISSN: None     Source Type: Journal    
DOI: 10.1038/nrmicro2438     Document Type: Review

References (147)

1. Hotez, P. J. et al. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118, 1311-1321 (2008).
2. Hotez, P. J., Bethony, J. M., Oliveira, S. C., Brindley, P. J. & Loukas, A. Multivalent anthelminthic vaccine to prevent hookworm and schistosomiasis. Expert Rev. Vaccines 7, 745-752 (2008).
3. WHO Expert Committee. Prevention and control of schistosomiasis and soil-transmitted helminthiasis. World Health Organ. Tech. Rep. Ser. 912, 1-57 (2002).
4. King, C. H., Dickman, K. & Tisch, D. J. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 365, 1561-1569 (2005).
5. Hotez, P. J. et al. Incorporating a rapid-impact package for neglected tropical diseases with programs for HIV/AIDS, tuberculosis, and malaria. PLoS Med. 3, e102 (2006).
6. King, C. H. & Dangerfield-Cha, M. The unacknowledged impact of chronic schistosomiasis. Chronic Illn. 4, 65-79 (2008).
7. Bleakley, H. Disease and development: evidence from hookworm eradication in the American South. Q. J. Econ. 122, 73-117 (2007).
8. Hotez, P. J., Fenwick, A., Savioli, L. & Molyneux, D. H. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373, 1570-1575 (2009).
9. King, C. H. Parasites and poverty: the case of schistosomiasis. Acta Trop. 113, 95-104 (2010).
10. Hotez, P. J. et al. Control of neglected tropical diseases. N. Engl. J. Med. 357, 1018-1027 (2007).
11. Finkelman, F. D. et al. Interleukin-4-and interleukin-13-mediated host protection against intestinal nematode parasites. Immunol. Rev. 201, 139-155 (2004).
12. Brooker, S., Bethony, J. & Hotez, P. J. Human hookworm infection in the 21st century. Adv. Parasitol. 58, 197-288 (2004). (Pubitemid 39643145)
13. Hotez, P. J. et al. Hookworm infection. N. Engl. J. Med. 351, 799-807 (2004).
14. Hotez, P. J., Bethony, J., Bottazzi, M. E., Brooker, S. & Buss, P. Hookworm: "the great infection of mankind". PLoS Med. 2, e67 (2005).
15. Bethony, J. et al. Soil-transmitted helminth infections: ascariasis, trichuriasis, and hookworm. Lancet 367, 1521-1532 (2006).
16. Gryseels, B., Polman, K., Clerinx, J. & Kestens, L Human schistosomiasis. Lancet 368, 1106-1118 (2006).
17. Steinmann, P, Keiser, J., Bos, R., Tanner, M. & Utzinger, J. Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk. Lancet Infect. Dis. 6, 411-425 (2006).
18. de Silva, N. R. et al. Soil-transmitted helminth infections: updating the global picture. Trends Parasitol. 19, 547-551 (2003).
19. Hotez, P. J., Bottazzi, M. E., Franco-Paredes, C., Ault, S. K. & Periago, M. R. The neglected tropical diseases of Latin America and the Caribbean: a review of disease burden and distribution and a roadmap for control and elimination. PLoS Negl. Trop. Dis. 2, e300 (2008).
20. Hotez, P. J. & Kamath, A. Neglected tropical diseases in sub-Saharan Africa: review of their prevalence, distribution, and disease burden. PLoS Negl. Trop. Dis. 3, e412 (2009).
21. Stoll, N. R. This wormy world. J. Parasitol. 33, 1-18 (1947).
22. Tissenbaum, H. A. et al. A common muscarinic pathway for diapause recovery in the distantly related nematode species Caenorhabditis elegans and Ancylostoma caninum. Proc. Natl Acad. Sci. USA 97, 460-465 (2000).
23. Williamson, A. L. et al. A multi-enzyme cascade of hemoglobin proteolysis in the intestine of blood-feeding hookworms. J. Biol. Chem. 279, 35950-35957 (2004).
24. Ranjit, N. et al. Proteolytic degradation of hemoglobin in the intestine of the human hookworm Necator americanus. J. Infect. Dis. 199, 904-912 (2009).
25. Zhan, B. et al. Biochemical characterization and vaccine potential of a heme-binding glutathione transferase from the adult hookworm Ancylostoma caninum. Infect. Immun. 73, 6903-6911 (2005).
26. Zhan, B. et al. Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus. Infect. Immun. 78, 1552-1563 (2010).
27. Wilson, M. S. et al. Immunopathology of schistosomiasis. Immunol. Cell Biol. 85, 148-154 (2007).
28. Tolentino, K. & Friedman, J. F An update on anemia in less developed countries. Am. J. Trop. Med. Hyg. 77, 44-51 (2007).
29. WHO. Iron deficiency anaemia: assessment, prevention and control. A guide for programme managers. (WHO, Geneva, 2001).
30. Stoltzfus, R. J. Iron deficiency: global prevalence and consequences. Food Nutr. Bull. 24, S99-S103 (2003).
31. Larocque, R., Casapia, M., Gotuzzo, E. & Gyorkos, T. W. Relationship between intensity of soiltransmitted helminth infections and anemia during pregnancy. Am. J. Trop. Med. Hyg. 73, 783-789 (2005).
32. Crompton, D. W. The public health importance of hookworm disease. Parasitology 121, S39-S50 (2000).
33. Food and Agriculture Organization (FAO) & WHO. Human Vitamin and Mineral Requirements: Report of a Joint FAO/WHO Expert Consultation. 113-2. 21 (FAO/WHO, Rome 2002).
34. Stoltzfus, R. J., Dreyfuss, M. L., Chwaya, H. M. & Albonico, M. Hookworm control as a strategy to prevent iron deficiency. Nutr. Rev. 55, 223-232 (1997).
35. Brooker, S. et al. Age-related changes in hookworm infection, anaemia and iron deficiency in an area of high Necator americanus hookworm transmission in south-eastern Brazil. Trans. R. Soc. Trop. Med. Hyg. 101, 146-154 (2007).
36. Brooker, S. et al. The epidemiology of hookworm infection and its contribution to anaemia among pre-school children on the Kenyan coast. Trans. R. Soc. Trop. Med. Hyg. 93, 240-246 (1999).
37. Sousa-Figueiredo, J. C. et al. A parasitological survey, in rural Zanzibar, of pre-school children and their mothers for urinary schistosomiasis, soil-transmitted helminthiases and malaria, with observations on the prevalence of anaemia. Ann. Trop. Med. Parasitol. 102, 679-692 (2008).
38. Calis, J. C. et al. Severe anemia in Malawian children. N. Engl. J. Med. 358, 888-899 (2008).
39. Nguyen, P. H. et al. Risk factors for anemia in Vietnam. Southeast Asian J. Trop. Med. Public Health 37, 1213-1223 (2006).
40. Dreyfuss, M. L. et al. Hookworms, malaria and vitamin A deficiency contribute to anemia and iron deficiency among pregnant women in the plains of Nepal. J. Nutr. 130, 2527-2536 (2000).
41. Brooker, S., Hotez, P. J. & Bundy, D. A. Hookworm-related anaemia among pregnant women: a systematic review. PLoS Negl. Trop. Dis. 2, e291 (2008).
42. Smith, J. L. & Brooker, S. Impact of hookworm infection and deworming on anaemia in non-pregnant populations: a systematic review. Trop. Med. Int. Health 15, 776-795 (2010).
43. Stephenson, L. The impact of schistosomiasis on human nutrition. Parasitology 107, S107-S123 (1993).
44. Sturrock, R. F et al. Schistosomiasis mansoni in Kenya: relationship between infection and anaemia in schoolchildren at the community level. Trans. R. Soc. Trop. Med. Hyg. 90, 48-54 (1996).
45. Friedman, J. F et al. Relationship between Schistosoma japonicum and nutritional status among children and young adults in Leyte, the Philippines. Am. J. Trop. Med. Hyg. 72, 527-533 (2005).
46. Friedman, J. F., Kanzaria, H. K. & McGarvey, S. T Human schistosomiasis and anemia: the relationship and potential mechanisms. Trends Parasitol. 21, 386-392 (2005).
47. Koukounari, A. et al. Morbidity indicators of Schistosoma mansoni: relationship between infection and anemia in Ugandan schoolchildren before and after praziquantel and albendazole chemotherapy. Am. J. Trop. Med. Hyg. 75, 278-286 (2006).
48. Koukounari, A. et al. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J. Infect. Dis. 196, 659-669 (2007).
49. Koukounari, A. et al. Relationships between anaemia and parasitic infections in Kenyan schoolchildren: a Bayesian hierarchical modelling approach. Int. J. Parasitol. 38, 1663-1671 (2008).
50. Tohon, Z. B. et al. Controlling schistosomiasis: significant decrease of anaemia prevalence one year after a single dose of praziquantel in Nigerian schoolchildren. PLoS Negl. Trop. Dis. 2, e241 (2008).
51. Prual, A. et al. Consequences of Schistosoma haematobium infection on the iron status of schoolchildren in Niger. Am. J. Trop. Med. Hyg. 47, 291-297 (1992).
52. Friedman, J. F., Mital, P., Kanzaria, H. K., Olds, G. R. & Kurtis, J. D. Schistosomiasis and pregnancy. Trends Parasitol. 23, 159-164 (2007).
53. Ajanga, A. et al. Schistosoma mansoni in pregnancy and associations with anaemia in northwest Tanzania. Trans. R. Soc. Trop. Med. Hyg. 100, 59-63 (2006).
54. Stephenson, L. S. Helminth parasites, a major factor in malnutrition. World Health Forum 15, 169-172 (1994).
55. Stephenson, L. S. et al. Relationships of Schistosoma haematobium, hookworm and malarial infections and metrifonate treatment to growth of Kenyan school children. Am. J. Trop. Med. Hyg. 34, 1109-1118 (1985).
56. Lwambo, N. J., Siza, J. E., Brooker, S., Bundy, D. A. & Guyatt, H. Patterns of concurrent hookworm infection and schistosomiasis in schoolchildren in Tanzania. Trans. R. Soc. Trop. Med. Hyg. 93, 497-502 (1999).
57. Guyatt, H. L., Brooker, S., Kihamia, C. M., Hall, A. & Bundy, D. A. Evaluation of efficacy of school-based anthelmintic treatments against anaemia in children in the United Republic of Tanzania. Bull. World Health Organ. 79, 695-703 (2001).
58. Friis, H. et al. Effects on haemoglobin of multi-micronutrient supplementation and multi-helminth chemotherapy: a randomized, controlled trial in Kenyan school children. Eur. J. Clin. Nutr. 57, 573-579 (2003).
59. Raso, G. et al. An integrated approach for risk profiling and spatial prediction of Schistosoma mansoni-hookworm coinfection. Proc. Natl Acad. Sci. USA 103, 6934-6939 (2006).
60. Brito, L. L. et al. Moderate-and low-intensity co-infections by intestinal helminths and Schistosoma mansoni, dietary iron intake, and anemia in Brazilian children. Am. J. Trop. Med. Hyg. 75, 939-944 (2006).
61. Fleming, F M. et al. Synergistic associations between hookworm and other helminth species in a rural community in Brazil. Trop. Med. Int. Health 11, 56-64 (2006).
62. Ezeamama, A. E. et al. The synergistic effect of concomitant schistosomiasis, hookworm, and trichuris infections on children's anemia burden. PLoS Negl. Trop. Dis. 2, e245 (2008).
63. Brooker, S. et al. Epidemiology of plasmodium-helminth co-infection in Africa: populations at risk, potential impact on anemia, and prospects for combining control. Am. J. Trop. Med. Hyg. 77, 88-98 (2007).
64. Demissie, F, Kebede, A., Shimels, T. & Beyene, P. Assessment of public health implication of malaria-geohelminth co-infection with an emphasis on hookworm-malaria anemia among suspected malaria patients in Asendabo, southwest Ethiopia. Ethiop. Med. J. 47, 153-158 (2009).
65. Kjetland, E. F et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20, 593-600 (2006).
66. Chenine, A. L. et al. Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure. PLoS Negl. Trop. Dis. 2, e265 (2008).
67. Da'dara, A. A. & Harn, D. A. Elimination of helminth infection restores HIV-1C vaccine-specific T cell responses independent of helminth-induced IL-10. Vaccine 28, 1310-1317 (2010).
68. Bentwich, Z., Teicher, C. L. & Borkow, G. The helminth HIV connection: time to act. AIDS 22, 1611-1614 (2008).
69. Moore, R. D. Anemia and human immunodeficiency virus disease in the era of highly active antiretroviral therapy Semin. Hematol. 37, 18-23 (2000).
70. Moraes, L. R., Cancio, J. A. & Cairncross, S. Impact of drainage and sewerage on intestinal nematode infections in poor urban areas in Salvador, Brazil. Trans. R. Soc. Trop. Med. Hyg. 98, 197-204 (2004).
71. Asaolu, S. O. & Ofoezie, I. E. The role of health education and sanitation in the control of helminth infections. Acta Trop. 86, 283-294 (2003)
72. WHO. Preventive chemotherapy in human helminthiasis: coordinated use of anthelminthic drugs in control interventions: a manual for health professionals and programme managers. (WHO, Geneva, 2006)
73. WHO. Soil-transmitted helminthiasis. Progress report on number of children treated with anthelminthic drugs: an update towards the 2010 global target. Wkly Epidemiol. Rec. 82, 237-252 (2008).
74. Olsen, A. Efficacy and safety of drug combinations in the treatment of schistosomiasis, soil-transmitted helminthiasis, lymphatic filariasis and onchocerciasis. Trans. R. Soc. Trop. Med. Hyg. 101, 747-758 (2007).
75. Hotez, P. J. Mass drug administration and integrated control for the world's high-prevalence neglected tropical diseases. Clin. Pharmacol. Ther. 85, 659-664 (2009).
76. Geary, T. G. et al. Unresolved issues in anthelmintic pharmacology for helminthiases of humans. Int. J. Parasitol. 40, 1-13 (2010).
77. Keiser, J. & Utzinger, J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA 299, 1937-1948 (2008).
78. Albonico, M. et al. Efficacy of mebendazole and levamisole alone or in combination against intestinal nematode infections after repeated targeted mebendazole treatment in Zanzibar. Bull. World Health Organ. 81, 343-352 (2003).
79. Geerts, S. & Gryseels, B. Drug resistance in human helminths: current situation and lessons from livestock. Clin. Microbiol. Rev. 13, 207-222 (2000).
80. Albonico, M. et al. Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area. Trans. R. Soc. Trop. Med. Hyg. 89, 538-541 (1995).
81. Hotez, P. J. & Ferris, M. T The antipoverty vaccines. Vaccine 24, 5787-5799 (2006).
82. Loukas, A., Bethony, J., Brooker, S. & Hotez, P. Hookworm vaccines: past, present, and future. Lancet Infect. Dis. 6, 733-741 (2006).
83. Bethony J. M., Loukas, A., Hotez, P. J. & Knox, D. P. Vaccines against blood-feeding nematodes of humans and livestock. Parasitology 133, S63-S79 (2006).
84. Diemert, D. J., Bethony J. M. & Hotez, P. J. Hookworm vaccines. Clin. Infect. Dis. 46, 282-288 (2008).
85. Bottazzi, M. E. & Brown, A. S. Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm. Expert Rev. Vaccines 7, 1481-1492 (2008).
86. Hotez, P. J. & Brown, A. S. Neglected tropical disease vaccines. Biologicals 37, 160-164 (2009).
87. Miller, T A. Industrial development and field use of the canine hookworm vaccine. Adv. Parasitol. 16, 333-342 (1978).
88. Bergquist, R., Utzinger, J. & McManus, D. P. Trick or treat: the role of vaccines in integrated schistosomiasis control. PLoS Negl. Trop. Dis. 2, e244 (2008).
89. Urquhart, G. M. Field experience with the bovine lungworm vaccine. Dev. Biol. Stand. 62, 109-112 (1985).
90. Meissner, B., Boll., M., Daniel, H. & Baumeister, R. Deletion of the intestinal peptide transporter affects insulin and TOR signaling in Caenorhabditis elegans. J. Biol. Chem. 279, 36739-36745 (2004).
91. Brophy, P. M. & Pritchard, D. I. Metabolism of lipid peroxidation products by the gastro-intestinal nematodes Necator americanus, Ancylostoma ceylanicum and Heligmosomoides polygyrus. Int. J. Parasitol. 22, 1009-1012 (1992).
92. Zhan, B. et al. Molecular cloning and purification of Ac-TMP, a developmentally regulated putative tissue inhibitor of metalloprotease released in relative abundance by adult Ancylostoma hookworms. Am. J. Trop. Med. Hyg. 66, 238-244 (2002).
93. Deponte, M. & Becker, K. Glutathione S-transferase from malarial parasites: structural and functional aspects. Methods Enzymol. 401, 241-253 (2005).
94. Jani, D. et al. HDP\a novel heme detoxification protein from the malaria parasite. PLoS Pathog. 4, e1000053 (2008).
95. Asojo, O. A. et al. X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus. BMC Struct. Biol. 7, 42 (2007).
96. van Rossum, A. J. et al. Binding of hematin by a new class of glutathione transferase from the blood-feeding parasitic nematode Haemonchus contortus. Infect. Immun. 72, 2780-2790 (2004).
97. Schuller, D. J. et al. Crystal structure of a new class of glutathione transferase from the model human hookworm nematode Heligmosomoides polygyrus. Proteins 61, 1024-1031 (2005).
98. Xiao, S. et al. The evaluation of recombinant hookworm antigens as vaccines in hamsters (Mesocricetus auratus) challenged with human hookworm, Necator americanus. Exp. Parasitol. 118, 32-40 (2008)
99. Veerapathran, A., Dakshinamoorthy G., Gnanasekar, M., Reddy, M. V. & Kalyanasundaram, R. Evaluation of Wuchereria bancrofti GST as a vaccine candidate for lymphatic filariasis. PLoS Negl. Trop. Dis. 3, e457 (2009).
100. Pearson M. S. et al. An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection. FASEB J. 23 3007-3019 (2009).
101. Yusibov, V. & Rabindran, S. Recent progress in the development of plant derived vaccines. Expert Rev. Vaccines 7, 1173-1183 (2008).
102. Loukas, A. et al. Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs. PLoS Med. 2, e295 (2005).
103. Pearson M. S. et al. Neutralizing antibodies to the hookworm hemoglobinase Na-APR-1: implications for a multivalent vaccine against hookworm infection and schistosomiasis. J. Infect. Dis. 201. 1561-1569 (2010).
104. Ranjit, N., Jones, M. K., Stenzel, D. J., Gasser, R. B. & Loukas, A. A survey of the intestinal transcriptomes of the hookworms, Necator americanus and Ancylostoma caninum, using tissues isolated by laser microdissection microscopy. Int. J. Parasitol. 36, 701-710 (2006).
105. Geldhof, P. & Knox, D. The intestinal contortin structure in Haemonchus contortus: An immobilised anticoagulant? Int. J. Parasitol. 38, 1579-1588 (2008).
106. Bethony, J. et al. Antibodies against a secreted protein from hookworm larvae reduce the intensity of hookworm infection in humans and vaccinated laboratory animals. FASEB J. 19, 1743-1745 (2005).
107. Goud, G. N. et al. Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials. Vaccine 23, 4754-4764 (2005).
108. Fujiwara, R. T. et al. Immunogenicity of the hookworm Na-ASP-2 vaccine candidate: characterization of humoral and cellular responses after vaccination in the Sprague Dawley rat. Hum. Vaccin. 1, 123-128 (2005).
109. H2 protective response in dogs. Vaccine 24, 501-509 (2006).
110. McManus, D. P. & Loukas, A. Current status of vaccines for schistosomiasis. Clin. Microbiol. Rev. 21, 225-242 (2008).
111. King, C. H., Sturrock, R. F, Kariuki, H. C. & Hamburger, J. Transmission control for schistosomiasis-why it matters now. Trends Parasitol. 22, 575-582 (2006).
112. Oliveira, S. C., Fonseca, C. T., Cardoso, F C., Farias, L P. & Leite, L. C. Recent advances in vaccine research against schistosomiasis in Brazil. Acta Trop. 108, 256-262 (2008).
113. Correa-Oliveira, R., Caldas, I. R. & Gazzinelli, G. Natural versus drug-induced resistance in Schistosoma mansoni infection. Parasitol. Today 16, 397-399 (2000).
114. Capron, A., Riveau, G., Capron, M. & Trottein, F Schistosomes: the road from host-parasite interactions to vaccines in clinical trials. Trends Parasitol. 21, 143-149 (2005).
115. Moser, D., Tendler, M., Griffiths, G. & Klinkert, M. Q. A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins. J. Biol. Chem. 266, 8447-8454 (1991).
116. Tendler, M. & Simpson, A. J. The biotechnology-value chain: development of Sm 14 as a schistosomiasis vaccine. Acta Trop. 108, 263-266 (2008).
117. Ramos, C. R. et al. Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate. Biochim. Biophys. Acta 1794, 655-662 (2009).
118. Zhang, W. et al. Sm-p80-based DNA vaccine provides baboons with levels of protection against Schistosoma mansoni infection comparable to those achieved by the irradiated cercarial vaccine. J. Infect. Dis. 201, 1105-1112 (2010).
119. Jiz, M. et al. Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica. Infect. Immun. 76, 3164-3169 (2008).
120. Loukas, A., Tran, M. & Pearson, M. S. Schistosome membrane proteins as vaccines. Int. J. Parasitol. 37, 257-263 (2007).
121. Braschi, S. & Wilson, R. A. Proteins exposed at the adult schistosome surface revealed by biotinylation. Mol. Cell. Proteomics 5, 347-356 (2006).
122. Tran, M. H. et al. Tetraspanins on the surface of Schistosoma mansoni are protective antigens against schistosomiasis. Nature Med. 12, 835-840 (2006).
123. Cardoso, F C., Pacifico, R. N., Mortara, R. A. & Oliveira, S. C. Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. Clin. Exp. Immunol. 144, 382-391 (2006).
124. Cardoso, F C. et al. Schistosoma mansoni tegument protein Sm29 is able to induce a Th 1-type of immune response and protection against parasite infection. PLoS Negl. Trop. Dis. 2, e308 (2008).
125. Yuan, C. et al. Schistosoma japonicum: Efficient and rapid purification of the tetraspanin extracellular loop 2, a potential protective antigen against schistosomiasis in mammalian. Exp. Parasitol. 126, 456-461 (2010).
126. Tran, M. H. et al. Suppression of mRNAs encoding tegument tetraspanins from Schistosoma mansoni results in impaired tegument turnover. PLoS Pathog. 6, e1000840 (2010).
127. Gobert, G. N. et al. Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes. PLoS Negl. Trop. Dis. 4, e600 (2010).
128. Fitzpatrick, J. M. et al. Anti-schistosomal intervention targets identified by lifecycle transcriptomic analyses. PLoS Negl. Trop. Dis. 3, e543 (2009).
129. Da'dara, A. A. et al. DNA-based vaccines protect against zoonotic schistosomiasis in water buffalo. Vaccine 26, 3617-3625 (2008).
130. Morel, C. M. et al. Health innovation networks to help developing countries address neglected diseases. Science 309, 401-404 (2005).
131. WHO. Deworming for Health and Development 2 7 (WHO, Geneva, 2005).
132. Maizels, R. M. et al. Helminth parasites-masters of regulation. Immunol. Rev. 201, 89-1 16 (2004).
133. Maizels, R. M., Holland, M. J., Falcone, F H., Zang, X. X. & Yazdanbakhsh, M. Vaccination against helminth parasites-the ultimate challenge for vaccinologists? Immunol. Rev. 171, 125-147 (1999).
134. Bethony, J. et al. Emerging patterns of hookworm infection: influence of aging on the intensity of Necator infection in Hainan Province, People's Republic of China. Clin. Infect. Dis. 35, 1336-1344 (2002).
135. Andrade, Z. A. Schistosomiasis and liver fibrosis. Parasite Immunol. 31, 656-663 (2009).
136. Erb, K. J. Helminths, allergic disorders and IgE-mediated immune responses: where do we stand? Eur J. Immunol. 37, 1170-1173 (2007).
137. Cohen, M. S., Hellmann, N., Levy, J. A., DeCock, K. & Lange, J. The spread, treatment, and prevention of HIV-1: evolution of a global pandemic. J. Clin. Invest. 118, 1244-1254 (2008).
138. WHO. World health report 2004: changing history (WHO, Geneva, 2004).
139. Greenwood, B. M. et al. Malaria: progress, perils, and prospects for eradication. J. Clin. Invest. 118, 1266-1276 (2008).
140. Rowe, A. K. et al. The burden of malaria mortality among African children in the year 2000. Int. J. Epidemiol. 35, 691-704 (2006).
141. Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y. & Hay, S. I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 434, 214-217 (2005).
142. Vercruysse, J., Knox, D. P., Schetters, T P. & Willadsen, P. Veterinary parasitic vaccines: pitfalls and future directions. Trends Parasitol. 20, 488-492 (2004).
143. Ploeger, H. W. Dictyocaulus viviparus: re-emerging or never been away? Trends Parasitol. 18, 329-332 (2002).
144. McKeand, J. B. Vaccine development and diagnostics of Dictyocaulus viviparus. Parasitology 120, S17-S23 (2000).
145. Steves, F E., Baker, J. D., Hein, V D. & Miller, T A. Efficacy of a hookworm (Ancylostoma caninum) vaccine for dogs. J. Am. Vet. Med. Assoc. 163, 231-235 (1973).
146. Knox, D. P. et al. The nature and prospects for gut membrane proteins as vaccine candidates for Haemonchus contortus and other ruminant trichostrongyloids. Int. J. Parasitol. 33, 1129-1137 (2003).
147. Lightowlers, M. W. Cestode vaccines: origins, current status and future prospects. Parasitology 133, S27-S42 (2006).